Vitrolife AB

VTFN

Company Profile

  • Business description

    Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient’s fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

  • Contact

    Box 9080
    Gothenburg400 92
    SWE

    T: +46 317218000

    https://www.vitrolife.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    1,116

Stocks News & Analysis

stocks

PayPal earnings: Growth slows, new CEO appointed

We expect to lower our fair value estimate of PayPal stock.
stocks

Morningstar initiates on ASX income play

This REIT may be an option for investors seeking income.
stocks

What Goodman’s upcoming earnings could reveal about data centre & AI growth

Answering key questions about Goodman & its data centre pipeline ahead of earnings

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,204.6056.500.62%
CAC 408,261.4881.981.00%
DAX 4024,644.12136.67-0.55%
Dow JONES (US)49,521.42280.430.57%
FTSE 10010,475.88161.291.56%
HKSE26,847.3212.550.05%
NASDAQ23,153.40101.79-0.44%
Nikkei 22554,293.36427.30-0.78%
NZX 50 Index13,467.2954.850.41%
S&P 5006,915.232.58-0.04%
S&P/ASX 2008,927.8075.500.85%
SSE Composite Index4,102.2034.460.85%

Market Movers